Fund HoldingsLynx1 Capital Management LP

Total Portfolio Value
$282.24M
Total Bought
$280.97M
Total Sold
$0
Net Transaction
+$280.97M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
MERUS N V01,793,866+1,793,866089,62231.75%+89,622
STOKE THERAPEUTICS INC(STOK)05,187,191+5,187,191063,75122.59%+63,751
C4 THERAPEUTICS INC06,880,527+6,880,527039,21913.90%+39,219
GH RESEARCH PLC(GHRS)04,195,894+4,195,894028,0719.95%+28,071
TSCAN THERAPEUTICS INC05,224,600+5,224,600026,0199.22%+26,019
ALLOGENE THERAPEUTICS INC06,202,374+6,202,374017,3676.15%+17,367
CULLINAN THERAPEUTICS INC(CGEM)0410,830+410,83006,8772.44%+6,877
PASSAGE BIO INC08,426,955+8,426,95505,8992.09%+5,899
CARIBOU BIOSCIENCES INC0680,189+680,18901,3330.47%+1,333
KODIAK SCIENCES INC(KOD)0271,177+271,17707080.25%+708
IBIO INC600,000862,279+262,2791,2661,9140.68%+648
PIERIS PHARMACEUTICALS INC037,436+37,43606210.22%+621
CENTESSA PHARMACEUTICALS PLC017,400+17,40002780.10%+278
BIONOMICS LIMITED0549,673+549,67302410.09%+241
KINIKSA PHARMACEUTICALS INTL(KNSA)08,231+8,23102060.07%+206
TENAX THERAPEUTICS INC014,751+14,7510510.02%+51
CENTURY THERAPEUTICS INC019,028+19,0280330.01%+33
VYNE THERAPEUTICS INC016,194+16,1940300.01%+30
Page 1 of 1